AstraZeneca Pharma India (NSE:ASTRAZEN) Inventory Turnover: 0.38 (As of Mar. 2026)

What is AstraZeneca Pharma India Inventory Turnover?

AstraZeneca Pharma India NSE:ASTRAZEN +0.83% 93 Inventory Turnover is 0.38 as of Mar. 2026. GuruFocus rates NSE:ASTRAZEN with a GF Score™ of 93/100 and a GF Value™ of ₹10,922.11 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. AstraZeneca Pharma India's Cost of Goods Sold for the three months ended in Mar. 2026 was ₹3,943 Mil. AstraZeneca Pharma India's Average Total Inventories for the quarter that ended in Mar. 2026 was ₹10,273 Mil. AstraZeneca Pharma India's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.38.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. AstraZeneca Pharma India's Days Inventory for the three months ended in Mar. 2026 was 237.78.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. AstraZeneca Pharma India's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.78.

AstraZeneca Pharma India (NSE:ASTRAZEN) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

AstraZeneca Pharma India's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	10273.3	/	3942.5	*	365 / 4
	=	237.78

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

AstraZeneca Pharma India's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	10273.3	/	5786.1
	=	1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

AstraZeneca Pharma India Inventory Turnover Related Terms

AstraZeneca Pharma India Inventory Turnover Historical Data

* Premium members only.

The historical data trend for AstraZeneca Pharma India's Inventory Turnover can be seen below:

AstraZeneca Pharma India Inventory Turnover Chart

AstraZeneca Pharma India Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Inventory Turnover

Get a 7-Day Free Trial

2.38

2.57

3.22

2.48

1.75

AstraZeneca Pharma India Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.47	0.54	0.42	0.47	0.38

93GF Score

AstraZeneca Pharma India Ltd NSE:ASTRAZEN

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

AstraZeneca Pharma India Inventory Turnover Calculation

AstraZeneca Pharma India's Inventory Turnover for the fiscal year that ended in Mar. 2026 is calculated as

	Inventory Turnover (A: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Mar. 2026 )	/ (	(Total Inventories (A: Mar. 2025 )	+	Total Inventories (A: Mar. 2026 ))	/	count )
=	13805.4	/ (	(5485	+	10273.3)	/	2 )
=	13805.4	/	7879.15
=	1.75

AstraZeneca Pharma India's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	3942.5	/ (	(0	+	10273.3)	/	1 )
=	3942.5	/	10273.3
=	0.38

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.38 mean?

AstraZeneca Pharma India (NSE:ASTRAZEN) has a Inventory Turnover of 0.38 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on AstraZeneca Pharma India and its competitors.

Is AstraZeneca Pharma India's Inventory Turnover too high?

AstraZeneca Pharma India's current Inventory Turnover is 0.38. Overall, AstraZeneca Pharma India has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does AstraZeneca Pharma India's Inventory Turnover compare to ZTS and UTHR?

AstraZeneca Pharma India's Inventory Turnover of 0.38 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on AstraZeneca Pharma India and its competitors. AstraZeneca Pharma India's current Inventory Turnover is 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AstraZeneca Pharma India stock overvalued right now?

Based on GuruFocus' analysis, AstraZeneca Pharma India (NSE:ASTRAZEN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹10,922.11, compared to a current price of ₹8,310.50 — trading 23.9% below its estimated fair value. The current Inventory Turnover is 0.38. AstraZeneca Pharma India's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For AstraZeneca Pharma India (NSE:ASTRAZEN), the current Inventory Turnover is 0.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AstraZeneca Pharma India (NSE:ASTRAZEN) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca Pharma India stock appears to be undervalued. The current stock price of ₹8,310.50 is trading 23.9% below its estimated GF Value™ of ₹10,922.11. GuruFocus considers AstraZeneca Pharma India to be Modestly Undervalued.

Key valuation signals for NSE:ASTRAZEN:

Inventory Turnover: 0.38
GF Value™: ₹10,922.11 vs. price of ₹8,310.50 (23.9% below fair value)
GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTRAZEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AstraZeneca Pharma India Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:540596 BOM:543635 BOM:524742 BOM:532482 BOM:524558 BOM:543064 BOM:524816 BOM:530019 BOM:533573 BOM:543322 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 506820:India

Address Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045

Website https://www.astrazeneca.com

AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines. The company operates within India, and outside, like Cambridge, Gothenburg, and Gaithersburg. The majority of revenue is from India.

93GF Score

Get the complete analysis for NSE:ASTRAZEN

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,310.50

Price

₹10,922.11

GF Value

View NSE:ASTRAZEN Analysis

See Inventory Turnover data for all stocks →